» Articles » PMID: 2420803

The Analysis of Lipopolysaccharide (endotoxin) in Meningococcal Polysaccharide Vaccines by Silver Staining Following SDS-polyacrylamide Gel Electrophoresis

Overview
Journal J Biol Stand
Date 1986 Jan 1
PMID 2420803
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

A simple physical-chemical method for estimating the lipopolysaccharide (LPS, i.e. endotoxin) content of meningococcal polysaccharide vaccines is described. The low molecular weight LPS was first separated from the high molecular weight polysaccharide by SDS-polyacrylamide gel electrophoresis. The LPS was then selectively visualized by a highly sensitive silver stain which can detect 5 ng of meningococcal LPS. The method can detect concentrations of LPS in meningococcal polysaccharides as low as 0.01%, and was used to measure semiquantitatively the LPS in bulk powders of meningococcal polysaccharides and in vaccines in final containers. The LPS in the bulk powders and in the vaccines was also assayed by the gelation of Limulus polyphemus ameobocyte lysate and the results of the two methods were in agreement.

Citing Articles

Molecular Lipopolysaccharide Di-Vaccine Protects from Shiga-Toxin Producing Epidemic Strains of O157:H7 and O104:H4.

Dyatlov I, Svetoch E, Mironenko A, Eruslanov B, Firstova V, Fursova N Vaccines (Basel). 2022; 10(11).

PMID: 36366362 PMC: 9692684. DOI: 10.3390/vaccines10111854.


Lipopolysaccharide -mediated resistance to host antimicrobial peptides and hemocyte-derived reactive-oxygen species are the major Providencia alcalifaciens virulence factors in Drosophila melanogaster.

Shaka M, Arias-Rojas A, Hrdina A, Frahm D, Iatsenko I PLoS Pathog. 2022; 18(9):e1010825.

PMID: 36084158 PMC: 9491580. DOI: 10.1371/journal.ppat.1010825.


Synthesis and immunogenicity evaluation of Salmonella enterica serovar Paratyphi A O-specific polysaccharide conjugated to diphtheria toxoid.

Ali A, An S, Cui C, Haque A, Carbis R Hum Vaccin Immunother. 2014; 10(6):1494-8.

PMID: 24603090 PMC: 5396222. DOI: 10.4161/hv.28130.


Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine.

Oftung F, Naess L, Wetzler L, Korsvold G, Aase A, Hoiby E Infect Immun. 1999; 67(2):921-7.

PMID: 9916109 PMC: 96405. DOI: 10.1128/IAI.67.2.921-927.1999.


Human T-cell responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine.

Naess L, Oftung F, Aase A, Wetzler L, Sandin R, Michaelsen T Infect Immun. 1998; 66(3):959-65.

PMID: 9488382 PMC: 108002. DOI: 10.1128/IAI.66.3.959-965.1998.